MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer’s disease: Running Title: Role of miR-191-5p in Alzheimer’s disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disease. Multiple reports have elucidated that microRNAs are promising biomarkers for AD diagnosis and treatment. Herein, the effect of miR-191-5p on microglial cell injury and the underlying mechanism were explored. APP/PS1 transgenic mice...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Taylor & Francis Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/86808bc2de7e4cd59af49aca62e20d8a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|